Boehringer Ingelheim Animal Health USA Inc.
Duluth, GA Doing business as Boehringer Ingelheim Vetmedica Inc.
- UEI
- N8ZHMK52HNG9
- CAGE
- 50614
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3239 Satellite Blvd, Duluth, GA 30096, USA
- Website
- boehringer-ingelheim.com
- Founded
- 1885
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $6,683,037 |
| FY2025 | $7,597,312 |
| FY2024 | $7,683,804 |
| FY2023 | $5,543,249 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Agriculture | $6,683,103 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Artemis Technologies Inc. | Guelph, ON | 325414 Biological Product (except Diagnostic) Manufacturing |
| Bavarian Nordic, Inc. | Durham, NC | 325414 Biological Product (except Diagnostic) Manufacturing |
| Zoetis Inc. | Parsippany-Troy Hills, NJ | 325412 Pharmaceutical Preparation Manufacturing |
| Mission Rabies Usa, Inc. | Houston, TX | 541940 Veterinary Services |
| Applied Design Corporation | Boulder, CO | 541330 Engineering Services |
About the company
Boehringer Ingelheim Animal Health USA Inc., doing business as Boehringer Ingelheim Vetmedica Inc., manufactures and supplies oral rabies vaccine (ORV) baits to the federal government as a prime contractor on a full-and-open, sole-source basis with no SBA set-aside certifications. The Duluth, Georgia-based pharmaceutical and biologics manufacturer holds exclusive rights to RABORAL V-RG, the only licensed ORV bait product available in the United States, and operates five active indefinite-delivery contracts with the Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) Wildlife Services program.
Boehringer Ingelheim's federal footprint is heavily concentrated in wildlife rabies management. APHIS Wildlife Services accounts for 37 of 48 total awards (77% by count) and $98.5 million of the $114.6 million combined potential value (86%)—a near-total operational alignment with a single customer line of business. The remaining portfolio splits among APHIS Marketing and Regulatory Programs Business Services (3 awards, $15.1 million), the Department of Homeland Security Science and Technology Directorate ($916 thousand), Defense Logistics Agency Troop Support Medical (5 awards, $8 thousand), and the National Oceanic and Atmospheric Administration ($5 thousand). This concentration reflects Boehringer Ingelheim's unique market position as the sole qualified supplier of licensed rabies vaccine baits for federal wildlife control operations.
The vendor's five active IDCs with Wildlife Services carry a combined ceiling of approximately $47.4 million through June 2027, with the most recent single-award vehicle valued at $14.4 million (June 2024 through June 2027) and another at $9 million (September 2026 through December 2027). Task orders against the top five parent vehicles total 31 orders across $46.2 million in combined potential value. All awards carry firm fixed-price structures and sole-source designations; the vendor's exclusive manufacturing license eliminates competitive procurement across the entire federal portfolio.
Recent representative work includes a $3.2 million delivery order (September 2026) for 8,150 lots of RABORAL V-RG raccoon baits in coated sachet formulation, a $3.9 million order (May 2025) for ORV baits, and a $3.5 million order (March 2026) for oral rabies vaccine baits under the parent IDC. Activity has modulated across 2022–2026 (ranging from 3 to 6 awards per year), with only $3.2 million in combined potential value reaching ultimate completion within the next twenty-four months, indicating stable recompete exposure. The vendor operates with 100% prime award participation and zero subcontract footprint, delivering all work from its Duluth manufacturing facility.
Quick answers
Is Boehringer Ingelheim Animal Health USA Inc. registered in SAM.gov?
Yes. Boehringer Ingelheim Animal Health USA Inc.'s SAM.gov registration is active through January 13, 2027.
What is Boehringer Ingelheim Animal Health USA Inc.'s CAGE code?
Boehringer Ingelheim Animal Health USA Inc.'s CAGE code is 50614, and its Unique Entity ID (UEI) is N8ZHMK52HNG9.
How much has Boehringer Ingelheim Animal Health USA Inc. received in federal contracts?
Federal contracts obligated $7,597,312 to Boehringer Ingelheim Animal Health USA Inc. in fiscal year 2025 and $27,507,402 in fiscal years 2023 through 2027.
How does Boehringer Ingelheim Animal Health USA Inc. rank among federal contractors?
Boehringer Ingelheim Animal Health USA Inc. ranked #6 in NAICS 325414, #37 in PSC 6505 and #40 in NAICS 3254 in FY2025.
What is Boehringer Ingelheim Animal Health USA Inc.'s most recent federal award?
Boehringer Ingelheim Animal Health USA Inc.'s most recent federal contract award is Raboral VRG raccoon baits, coated sachets, 128370 (12639526F0890), from Marketing and Regulatory Programs Business Services (APHIS), on September 17, 2026.
On GovTribe
See Boehringer Ingelheim Animal Health USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors